analyse the outcome of patients diagnosed to have pancreatic cancer in clinical practice in North London. Methods In this duel centre retrospective study, a years worth of pancreatic cancer diagnoses was compiled using the North London Cancer Network Multi-disciplinary team meeting data base. The patients records were then searched gathering information on their dates of diagnosis; referral to our hepatobiliary surgeons at a local tertiary referral centre; whether they had a pre-operative stent; the date of their surgery (if they survived long enough to have it) and they're ultimate outcome. Results 68 patients within our sector received a diagnosis (histological/endoscopic/radiological) of pancreatic cancer over the course of 1 year (May 2010eMay 2011). Of this cohort 20 (29.4%) were referred for surgical opinion. During the lag between diagnosis and surgical review, 9 (45%) patients received endoscopic biliary drainage and stent insertion (all were 1st pass). The total number to ultimately receive their Whipple's was 5 (25%). In four patients in whom surgery was felt to be an option, aggressive disease and complications leading to a lengthy in patient stay at the point of diagnosis meant that the physical condition of the patient had deteriorated to the point where they were no longer fit for surgery/ inoperable. Only one patient proceeded straight to operation without prior stenting. Two patients had their operations privately. Unfortunately details of any post operative complications are not available. Conclusion Our experiences of pancreatic cancer is that at the point of diagnosis most cancers were inoperable 48 of 68 (70%). Within our study period only 5 of 68 (7%) patients had surgery for pancreatic cancer. The majority of patients even when initially considered for surgery (75%) do not end up having a resection. When patients are referred with symptoms of obstructive jaundice, knowing that the majority will not undergo surgery and also knowing in clinical practice that it is difficult to get surgical resection within 10 days of diagnosis, the humane thing to do instinctively is to stent and achieve biliary drainage. Achieving biliary drainage helps in improving the patients symptom profile and additionally allows chemotherapeutic options in those whose jaundice resolves. Introduction Patients with suspected pancreatic malignancy on cross sectional imaging are often referred for endoscopic investigations with a view to obtaining a definitive histological diagnosis. We aimed to assess the diagnostic yield of brushings and biopsies taken at endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound with fine needle aspiration (EUS FNA) in patients with pancreatic malignancy proven by operative histology.
Methods A retrospective audit of 125 patients undergoing surgery for pancreatic malignancy at the Royal Liverpool University Hospital (RLUH) from January 2009 to December 2011 was carried out. Of these patients, 35 underwent investigation at RLUH and are included in this analysis, two of these required two investigations. Fifty patients had ERCP at an external Trust and 40 patients went straight to surgery without endoscopic intervention. Data were extracted from the pancreatic surgery database and electronic patient records for demographics and histology reports taken at the time of endoscopy and surgery.
Results Overall 123 patients had operative histology confirming pancreatic adenocarcinoma, two patients had neuroendocrine tumour (NET) of the pancreas. Of the 35 patients undergoing investigation at RLUH, 34 had pancreatic adenocarcinoma and one had NET of the pancreas. Fifteen of 29 (52%) patients had brushings confirmatory of malignancy at ERCP, 9 of 29 (31%) had no malignant cells seen on brushings at ERCP, 3 of 29 (10%) had equivocal results suggestive but not diagnostic of malignancy. Brush cytology was not obtained in two patients, one patient suffered a perforation at ERCP requiring emergency surgery and one patient had failed cannulation of the CBD. Five of eight patients had an EUS FNA confirmatory of malignancy, two of eight had no malignant cells seen and 1 had equivocal results. In our cohort the sensitivity of ERCP alone is 56% (95% CI 36% to 74%) the combined sensitivity for ERCP and EUS 57% (95% CI 40% to 73%). Conclusion The sensitivity of brush cytology at ERCP for has previously been reported to be between 50% and 65% 1e3 for pancreatic malignancies. This is comparable to our findings in this cohort of patients with proven pancreatic malignancy. Positive histology from ERCP to EUS FNA can be confirmatory of pancreatic malignancy, but caution should be used when interpreting negative histology results given the intermediate sensitivity of these investigations. The laparoscopic and open groups were comparable for age (57 vs 63 years, p¼0.584), sex distribution and tumour size (3.9 vs 4 cm, p¼0.939). Both groups had a comparable number of malignant cases (56% vs 50%, p¼1.0). Although LDP took longer to complete (287.5 vs 240 min, p¼0.061), it was associated with significantly lower blood loss (300 vs 500 ml, p¼0.031) but comparable perioperative transfusion rate (p¼0.471). The laparoscopic approach was associated with a significantly higher spleen-preservation rate (overall: 50% vs 12.5%, p¼0.05; benign pathology: 85.7% vs 25%, p¼1.0). LDP patients had a significantly lower HDU stay (1 vs 4.5 days, p<0.001) and a significantly lower postoperative hospital stay (6.5 vs 13.5 days, p¼0.001). There was no significant difference in the postoperative morbidity and the R0 resection margin status. 
